SEC Form 4 · accession 0001645627-18-000077
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President
Period of report
Dec 4, 2018
Accepted (ET)
Dec 7, 2018 · 4:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 4, 2018 | P | 2,000 | $0.0337 | A | 26,289,098 | D | |
| Common Stock | Dec 4, 2018 | P | 5,000 | $0.0299 | A | 26,294,098 | D | |
| Common Stock | Dec 4, 2018 | P | 2,000 | $0.03 | A | 26,296,098 | D | |
| Common Stock | Dec 4, 2018 | P | 2,500 | $0.0299 | A | 26,298,598 | D | |
| Common Stock | Dec 4, 2018 | P | 1,000 | $0.0299 | A | 26,299,598 | D | |
| Common Stock | Dec 4, 2018 | P | 1,000 | $0.0298 | A | 26,300,598 | D | |
| Common Stock | Dec 4, 2018 | P | 1,000 | $0.0299 | A | 26,301,598 | D | |
| Common Stock | Dec 4, 2018 | P | 1,000 | $0.0298 | A | 26,302,598 | D | |
| Common Stock | Dec 4, 2018 | P | 1,000 | $0.0296 | A | 26,303,598 | D | |
| Common Stock | Dec 4, 2018 | P | 1,000 | $0.03 | A | 26,304,598 | D | |
| Common Stock | Dec 4, 2018 | P | 1,000 | $0.0296 | A | 26,305,598 | D | |
| Common Stock | Dec 4, 2018 | P | 1,000 | $0.0296 | A | 26,306,598 | D | |
| Common Stock | Dec 4, 2018 | P | 100 | $0.0299 | A | 26,306,698 | D | |
| Common Stock | Dec 4, 2018 | P | 1,000 | $0.0274 | A | 26,307,698 | D | |
| Common Stock | Dec 4, 2018 | P | 1,000 | $0.0275 | A | 26,308,698 | D | |
| Common Stock | Dec 4, 2018 | P | 1,000 | $0.0269 | A | 26,309,698 | D | |
| Common Stock | Dec 6, 2018 | P | 2,000 | $0.0268 | A | 26,311,698 | D | |
| Common Stock | Dec 6, 2018 | P | 2,000 | $0.027 | A | 26,313,698 | D |
Table II — derivative securities
No Table II lines on this filing.